Iridex Corporation announced the appointment of Beverly Huss to its board of directors, effective, March 17, 2022. In connection with Ms. Huss' appointment to the board, the size of the board was increased from five to six members as of the Effective Date. Ms. Huss brings more than 25 years of business operations, management, and corporate governance experience in the medical device industry.

Since January 2021, she has served as the CEO of Pagonia Medical Inc.; a private company focused on creating a novel non-invasive device for the preservation of tissue following a heart attack, stroke, or traumatic brain injury. In addition, from September 2013 until January 2021, she served as President and CEO of Qool Therapeutics Inc., a company focused on temperature management therapies. Before joining Qool, Ms. Huss was President and CEO at a start-up medical device company, Vibrynt Inc. She held multiple senior-level leadership positions at Guidant Corporation, including President, Endovascular Solutions, and Vice President, Global Marketing, Vascular Intervention, and Vice President of the Stent Business Unit.